Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like Study shows toddlers learn better from impossible events November 4, 2024 Exploring the impact of soy isoflavones in prostate cancer therapy November 23, 2023 SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness January 8, 2024